Super-mini percutaneous nephrolithotomy versus flexible ureteroscopy for renal stones ≤20 mm: A single-center randomized controlled trial with cost analysis and safety outcomes
Oct 2026· Urology Annals· Vol 18, pp. 322-327· 0 citations· 8 references
TL;DR
SMP reduces operative time and cost, while fURS results in less blood loss and shorter hospital stay, while fURS results in less blood loss and shorter hospital stay.
Abstract
Super-mini percutaneous nephrolithotomy (SMP) and flexible ureteroscopy (fURS) are minimally invasive for small renal stones, but comparative data on safety and cost in resource-limited settings are scarce.
The aim of this study was to compare the efficacy, safety, and cost of SMP and fURS for renal stones ≤20 mm.
This was a single-center, open-label randomized controlled trial at a tertiary-care hospital in Vietnam (2024).
Patients were randomized to SMP or fURS. The primary outcome was the stone-free rate (SFR) at 1 month, assessed by an independent blinded radiologist. The secondary outcomes included operative time, hemoglobin drop, hospital stay, complications, and total cost. Analysis was performed on an intention-to-treat basis. This trial is reported in accordance with the CONSORT 2025 statement (Supplementary File 1).
Continuous variables were compared using Student’s
t
-test or Mann–Whitney U test. Categorical variables were analyzed using Chi-square or Fisher’s exact tests where appropriate.
P
<0.05 was considered statistically significant.
The operative time was significantly shorter with SMP than fURS (65.42 ± 12.14 vs. 78.86 ± 13.66 min;
P
< 0.001). SMP showed a greater hemoglobin decrease (0.97 ± 0.77 vs. 0.43 ± 0.28 g/dL;
P
< 0.001) and a longer hospital stay (2.86 ± 0.76 vs. 2.17 ± 0.38 days;
P
< 0.001). At 1 month postoperatively, the primary SFR was higher in the SMP group than in the fURS group (94.4% vs. 88.9%); however, the difference was not statistically significant (risk difference, 5.6%; 95% confidence interval, −7.4% to 18.5%;
P
= 0.397). Total treatment cost was significantly lower in the SMP group (
P
< 0.001).
Both procedures are safe and effective. SMP reduces operative time and cost, while fURS results in less blood loss and shorter hospital stay.
Kidney stones in children have unique characteristics, including a smaller pelvicalyceal system and more delicate tissues. This work aimed to compare the safety and efficacy of retrograde intrarenal surgery using single-use flexible ureteroscopy (FURS) with mini-percutaneous nephrolithotomy (PCNL) in children with rena...
Mosab Eldeeb, S. Nagla, O. El-gamal et al.· African Journal of Urology· 0 citations
This study compared the clinical efficacy and postoperative quality of life of flexible ureteroscopy (fURS) versus percutaneous nephrolithotomy (PCNL) in patients with upper ureteral calculi (UUC). A total of 152 patients with UUC treated at Renhuai People's Hospital between January 2024 and January 2026 were enrolled...
Yuan-Ning Zhang, C. Cai, Ling Zhou et al.· American journal of translat...· 0 citations
FANS-RIRS is a viable salvage alternative for post-PCNL residual stones, particularly in higher-risk patients with poorer baseline renal function, particularly in higher-risk patients with poorer baseline renal function.
Zhong Wei, R. Tan, Zheng-Hang Ma et al.· Urolithiasis· 0 citations
BACKGROUND
Percutaneous nephrolithotomy (PCNL) is first-line treatment for large or complex renal calculi. The traditional papillary access is considered safer, while non-papillary access may offer procedural advantages. This systematic review and meta-analysis aims to evaluate the efficacy and safety of papillary vers...
Background: Percutaneous nephrolithotomy (PCNL) remains the reference treatment for renal stones larger than 2 cm because of its high single-session stone-free rate. However, advances in flexible ureteroscopy (fURS), laser lithotripsy, suction-assisted access systems, and endoscopic technology have expanded the role of...
Nidal Samira, Murad Asali· Journal of Clinical Medicine· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.